Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Hikal Ltd.
NSE: HIKAL
|
BSE: 524735
|
ISIN: INE475B01022
|
Industry: Pharmaceuticals
|
Expensive Performer
212.2100
-13.03
(
-5.78
%)
NSE
Oct 08, 2026
15:31 PM
45.10% Gain from 52W Low
Volume:
509.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Hikal Ltd.
16 Aug 2022
212.21
-5.78%
Hikal Ltd
Hold:
Hikal Ltd.
by
ICICI Direct
Target: 290
Recommendation
Target
ICICI Direct
Hikal has gained
28.47%
in the last 6 Months
More from Hikal Ltd.
Recommended
Market closes lower amid rising oil prices and persistent FII outflows
Trendlyne Marketwatch |
08 Oct 2026, 04:04PM
From power equipment to platforms: Where analysts see the strongest Q2FY27 revenue growth
The Baseline |
08 Oct 2026, 10:41AM
Earnings Call Transcript - Q4FY20 for Hikal Limited
|
23 Jun 2020